Price
Target price
?
?
0.900%
0.2
0.900%
-
09:32 / Stuttgart Stock Exchange
WKN: 905720 / Symbol: MATW / Name: Matthews / Stock / Personal &Household Products & Services / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Matthews International Corp. Stock
Matthews International Corp. gained 0.900% compared to yesterday.
Pros and Cons of Matthews International Corp. in the next few years
Pros
?
S********** s********
?
C******** o* t** e**********
?
M***** P*******
Cons
?
G***** c******* t* c**********
?
B****
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Matthews International Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Matthews International Corp. | 0.900% | -3.419% | -6.612% | 21.899% | 0.444% | -39.894% | -28.025% |
| Vuzix Corp. | -6.500% | -5.966% | 60.204% | 55.630% | 31.359% | -16.186% | -76.052% |
| USANA Health Sciences Inc. | 2.000% | 1.974% | -1.274% | -38.000% | -6.061% | -73.729% | -82.286% |
| Pola Orbis Holdings Inc. | 0.000% | 1.527% | -1.481% | -18.902% | -4.317% | -47.638% | -68.333% |
Comments
Matthews International Co. (NASDAQ: MATW) had its price target lowered by analysts at B. Riley from $54.00 to $40.00. They now have a "buy" rating on the stock.
Show more
Ratings data for MATW provided by MarketBeat
Matthews International Co. (NASDAQ: MATW) had its price target lowered by analysts at B. Riley from $61.00 to $59.00. They now have a "buy" rating on the stock.
Show more
Ratings data for MATW provided by MarketBeat
Matthews International Co. (NASDAQ: MATW) had its price target raised by analysts at B. Riley from $50.00 to $64.00. They now have a "buy" rating on the stock.
Show more
Ratings data for MATW provided by MarketBeat
News
Eton Pharmaceuticals Q1 Earnings Call Highlights
Eton Pharmaceuticals (NASDAQ:ETON) raised its 2026 revenue outlook after reporting record first-quarter product sales and highlighting early progress from two recent product launches, DESMODA and
AptarGroup Sets CEO Succession as 2025 Sales Rise and Shareholders Back Ballot
AptarGroup (NYSE:ATR) used its annual meeting to announce a planned chief executive transition, report that shareholders approved all items on the ballot and provide an update on 2025 performance
Is Yum China a Buy After Investment Firm Matthews Purchased Shares Worth $12.57 Million?
According to its SEC filing dated May 4, 2026, Matthews International Capital Management LLC purchased 242,785 additional shares of Yum China (NYSE:YUMC) in the first quarter.
The estimated value of
